Shell Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$253K Sell
492
-607
-55% -$265K 0.03% 435
2025
Q2
$345K Sell
1,099
-195
-15% -$58.5K 0.01% 595
2025
Q1
$394K Sell
1,294
-64
-5% -$21.5K 0.02% 529
2024
Q4
$451K Sell
1,358
-2
-0.1% -$678 0.02% 526
2024
Q3
$454K Buy
+1,360
New +$517K 0.02% 524
2024
Q1
$556K Sell
1,351
-146
-10% -$51.3K 0.03% 430
2023
Q4
$459K Sell
1,497
-451
-23% -$122K 0.02% 541
2023
Q3
$472K Sell
1,948
-34
-2% -$8.7K 0.02% 588
2023
Q2
$476K Sell
1,982
-11
-0.6% -$2.29K 0.02% 598
2023
Q1
$375K Sell
1,993
-7
-0.4% -$1.45K 0.02% 680
2022
Q4
$425K Sell
2,000
-406
-17% -$81.1K 0.02% 611
2022
Q3
$378K Buy
2,406
+161
+7% +$25.7K 0.01% 715
2022
Q2
$336K Buy
2,245
+586
+35% +$84.8K 0.01% 927
2022
Q1
$271K Sell
1,659
-246
-13% -$40.6K 0.01% 1078
2021
Q4
$415K Buy
1,905
+488
+34% +$102K 0.01% 980
2021
Q3
$268K Sell
1,417
-60
-4% -$10.9K 0.01% 1115
2021
Q2
$261K Buy
1,477
+80
+6% +$13.8K 0.01% 1164
2021
Q1
$229K Buy
+1,397
New +$214K ﹤0.01% 1116

Other funds holding MEDP

Shell Asset Management's MEDP Position: Q3 2025 in Review

Shell Asset Management reduced its Medpace (MEDP) stake by 55% in Q3 2025, selling an estimated $265K and leaving 492 shares worth $253K. The position accounts for 0.03% of the portfolio, ranked #435.

Shell Asset Management first reported a position in MEDP in Q1 2021 and has held it in 18 quarters since. The position peaked at $556K in Q1 2024. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Shell Asset Management held 492 shares of Medpace worth $253K as of Q3 2025.
  • Shell Asset Management sold 607 Medpace shares in Q3 2025, an estimated $265K.
  • Medpace made up 0.03% of Shell Asset Management's portfolio in Q3 2025, its #435 holding.
  • Shell Asset Management first reported a position in Medpace in Q1 2021 and has held it in 18 quarters since.
  • Shell Asset Management's Medpace position peaked at $556K in Q1 2024.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.